ProQR Therapeutics N.V Income Statement (2021-2025) | PRQR

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.17M0.49M1.03M0.27M1.27M0.99M0.82M0.73M0.70M1.31M1.49M3.53M4.83M6.79M4.22M4.60M4.75M4.32M3.37M
Operating items
Depreciation & Amortization - Total 761.13
Research & Development -10.74M-11.72M-13.12M-14.25M-15.00M-12.22M-15.48M92.88M-6.50M-6.43M-5.93M45.80M-10.08M-7.59M-10.34M66.36M-12.96M-12.91M-12.95M
Selling, General & Administrative -4.03M-4.96M-5.41M-6.08M-5.51M-5.77M-5.40M35.03M-4.32M-4.51M-3.61M29.83M-3.75M-3.24M-3.61M25.01M-3.40M-5.45M-3.65M
Other Operating Expenses 0.62M-1.21M
Operating Expenses -14.77M-16.69M-18.53M-20.33M-20.51M-17.99M-20.88M127.90M-10.83M-10.95M-9.54M75.62M-13.83M-10.83M-13.94M91.38M-16.36M-18.36M-16.60M
EBIT -15.21M-18.91M-17.73M-20.84M-15.84M-14.37M-23.43M-13.57M-9.50M-8.73M-5.94M-5.89M-8.32M-3.11M-8.90M-9.94M-10.60M-13.77M-12.87M
Non-operating items
Interest & Investment Income -0.35M-2.97M0.31M-0.34M0.92M-1.24M-0.60M4.00M0.58M-0.51M-0.40M2.48M0.53M0.55M-0.52M1.90M0.48M0.22M0.33M
Other Non Operating Income 477.67-0.17M0.24M
Net income details
EBT -15.21M-18.91M-17.73M-20.84M-15.84M-14.37M-23.43M-13.57M-9.50M-8.73M-5.94M-5.89M-8.32M-3.11M-8.90M-9.94M-10.60M-13.77M-12.87M
Profit After Tax -15.22M-18.97M-17.77M20.87M-15.84M-14.39M-23.50M-13.57M-9.50M-8.69M-5.90M-5.90M8.32M2.90M-8.90M-9.94M10.60M13.79M-12.87M
Equity Income 0.13M-0.26M-0.16M0.10M-0.01M0.02M-0.02M
Investment Income 0.62M0.31M-0.41M
Income from Non-Controlling Interests -0.01M-0.01M-0.03M-0.69M-0.01M0.23M0.01M-0.39M0.08M0.02M0.32M
Income from Continuing Operations -15.21M-18.91M-17.73M-20.84M-15.84M-14.37M-23.43M-13.57M-9.50M-8.73M-5.94M-5.89M-8.32M-3.11M-8.90M-9.94M-10.60M-13.77M-12.87M
Consolidated Net Income -15.21M-18.91M-17.73M-20.84M-15.84M-14.37M-23.43M-13.57M-9.50M-8.73M-5.94M-5.89M-8.32M-3.11M-8.90M-9.94M-10.60M-13.77M-12.87M
Income towards Parent Company -15.21M-19.13M-17.74M-20.84M-15.84M-14.62M-23.51M-13.57M-9.82M-8.70M-6.58M-5.31M-8.32M-2.90M-9.32M-9.84M-10.99M-14.56M-12.89M
Net Income towards Common Stockholders -15.21M-19.13M-17.74M-20.84M-15.84M-14.62M-23.51M-13.57M-9.82M-8.70M-6.58M-5.31M-8.32M-2.90M-9.32M-9.84M-10.99M-14.56M-12.89M
Additional items
EPS (Basic) -0.28-0.35-0.24-0.28-0.22-0.20-0.31-0.18-0.12-0.11-0.08-0.06-0.10-0.03-0.11-0.12-0.10-0.14-0.12
EPS (Weighted Average and Diluted) -0.25-0.24-0.22-0.20-0.19-0.33-0.19-0.11-0.10-0.07-0.06-0.09-0.03-0.10-0.11-0.10-0.12-0.10
Shares Outstanding (Weighted Average) 54.13M54.83M74.86M74.86M71.29M74.87M74.87M74.87M80.82M80.89M84.25M84.25M81.35M84.25M84.25M84.25M105.21M107.71M107.71M
Shares Outstanding (Diluted Average) 61.29M79.66M80.50M80.09M76.15M71.97M73.09M86.82M88.14M88.18M87.16M88.62M87.94M89.71M91.99M110.76M119.25M123.15M
EBITDA 14.74M-19.14M-17.53M-20.69M-15.59M13.65M-22.88M-13.57M-9.74M-8.68M6.26M-5.89M8.11M2.81M9.32M-9.94M10.99M14.56M-12.89M